Table 3.
Serum Uric Acid, Cholesterol, Amylase, and Fasting Blood Sugar Before and After Liver Transplantation in the Patients Studied
| Parameter | Group | Pretransplantation | Posttransplantation | P Value |
|---|---|---|---|---|
| Uric acid (mg/dl) | FK 506 | 4.5 ± 0.4* | 7.8 ± 1.0† | 0.007 |
| CyA | 4.2 ± 0.5 | 6.2 ± 0.9 | 0.063 | |
| Cholesterol (mg/dl) | FK 506 | 200.5 ± 37.3 | 123.7 ± 9.2‡ | 0.037 |
| CyA | 148.5 ± 25.0 | 168.5 ± 5.6 | 0.382 | |
| Amylase (IU/L) | FK 506 | 163 ± 86 | 53 ± 5‡ | 0.222 |
| CyA | 108 ± 13 | 79 ± 12 | 0.079 | |
| Fasting blood sugar (mg/dl) | FK 506 | 107 ± 8.0 | 137 ± 19 | 0.110 |
| CyA | 127 ± 12.0 | 134 ± 19 | 0.644 |
Not significantly different from the pretransplantation level in the CyA-treated group.
Not significantly different from the posttransplantation level in the CyA-treated group.
Significantly different from the value for the CyA-treated group at the same time in relation to the liver transplantation.